Evert B. Schimmelpennink - May 24, 2024 Form 4 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
Director
Signature
/s/ Peter Slover, Attorney-in-Fact
Stock symbol
CTNM
Transactions as of
May 24, 2024
Transactions value $
$0
Form type
4
Date filed
5/29/2024, 05:53 PM
Previous filing
Apr 4, 2024
Next filing
Jul 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Program, as amended. One-third of the option shares vest on April 5, 2025, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service.